The potential of Senicapoc, a KCNN4 inhibitor, for the prevention and treatment of breast cancer
G. Chenevix-Trench, K. Britt, C. Xiao, M. Miranda, W. Shi, J. Beesley, J. Saunus, A. Civitarese, D. Black, M. Ruppert, M. Perreira, S. Jackson, Z. Teale, D. Carter-Cusack, L. Kalinowski, , F. Al-Ejeh
This study investigates Senicapoc, a KCNN4 inhibitor, and finds it delays mammary tumor development and slows tumor growth in mouse models, suggesting potential for breast cancer prevention and treatment.
bioRxiv · Apr 25, 2023 · PreprintCancer Biology